ACTIVE

APHARMAT

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
53 k €
+138.6% YoY
Gross margin
234,8 k €
+33.0% YoY
Equity
49,7 k €
+1595.5% YoY
Workforce
1,9 ETP
+11.8% YoY

What does APHARMAT do?

APHARMAT is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 1,9 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0831.853.489
Incorporation
26/11/2010
Legal form
Private limited company
Registered office
Van Eycklei 47
2018 Antwerpen · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Average workforce
1,9 ETP
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores64200Activities of holding companies64210Activities of holding companies
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120152014201320122011
Income statement
Gross margin234,8 k €176,6 k €238,9 k €214,9 k €260,5 k €152,7 k €25,9 k €73,9 k €75 k €80,1 k €
EBITDA97,1 k €57,9 k €105,7 k €70,1 k €134,7 k €36,1 k €21,9 k €68,1 k €73,4 k €79,2 k €
Operating result93,3 k €54,7 k €102 k €67,5 k €130,7 k €31,5 k €21,7 k €68 k €69,9 k €75,1 k €
Net result53 k €22,2 k €59 k €37,1 k €84,1 k €22,1 k €-17,4 k €5,8 k €26,4 k €14,1 k €
Balance sheet
Equity49,7 k €-3,3 k €-25,5 k €-84,5 k €-121,6 k €-22,1 k €35,2 k €52,6 k €46,7 k €20,3 k €
Total assets1,4 M €1,4 M €1,4 M €1,4 M €1,4 M €1,9 M €1,5 M €1,5 M €1,5 M €1,5 M €
Cash7,8 k €6,1 k €36,4 k €17,9 k €44,1 k €22 k €2,8 k €3,4 k €2,3 k €5,9 k €
Debts1,4 M €1,4 M €1,4 M €1,5 M €1,5 M €1,9 M €1,4 M €1,4 M €1,5 M €1,5 M €
Other
Workforce1,9 ETP1,7 ETP2,1 ETP2,8 ETP2,8 ETP2,1 ETP––––
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 8 ended

Active mandates

Katelijne Valkaert

Bestuurder · since 26 juin 2020

Active
PHARMALIJN

Bestuurder · since 01 avril 2020 · 0860.097.218

Represented by Moorkens Roeland

Active

Ended mandates

Katelijne Valkaert

Director · since 26 juin 2020

Ended
PHARMALIJN

Director · since 01 avril 2020 · 0860.097.218

Represented by Moorkens Roeland

Ended
Pharmalijn BV

Bestuurder · since 01 avril 2020

Represented by Moorkens Roeland

Ended
Caroline Verlinden

Manager

Ended
At this address

Other companies at this address

CompanyCBE no.
GELANA FINANCE● Active
0441.478.771
MAVEX● Active
0474.373.253
Vereniging van Mede-eigenaars gebouw Antwerpen Van Eycklei 47● Active
0865.531.790
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/07/202614/07/202522/07/202405/05/202320/07/202205/08/2021
General meeting17/06/202618/06/202530/06/202402/05/202315/06/202216/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

15 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202517/06/202615/07/2026DutchPDF
Abridged model31/12/202418/06/202514/07/2025DutchPDF
Abridged model31/12/202330/06/202422/07/2024DutchPDF
Abridged model31/12/202202/05/202305/05/2023DutchPDF
Abridged model31/12/202115/06/202220/07/2022DutchPDF
Abridged model31/12/202016/06/202105/08/2021DutchPDF
Abridged model31/12/201917/06/202029/07/2020DutchPDF
Abridged model31/12/201819/06/201927/08/2019DutchPDF
Abridged model31/12/201720/06/201831/07/2018DutchPDF
Abridged model31/12/201621/06/201703/08/2017DutchPDF
Abridged model31/12/201515/06/201610/08/2016DutchPDF
Abridged model31/12/201417/06/201516/10/2015DutchPDF
Abridged model31/12/201318/06/201428/08/2014DutchPDF
Abridged model31/12/201219/06/201331/07/2013DutchPDF
Abridged model31/12/201127/06/201224/07/2012DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 8 ended

Active mandates

Katelijne Valkaert

Bestuurder · since 26 juin 2020

Active
PHARMALIJN

Bestuurder · since 01 avril 2020 · 0860.097.218

Represented by Moorkens Roeland

Active

Ended mandates

Katelijne Valkaert

Director · since 26 juin 2020

Ended
PHARMALIJN

Director · since 01 avril 2020 · 0860.097.218

Represented by Moorkens Roeland

Ended
Pharmalijn BV

Bestuurder · since 01 avril 2020

Represented by Moorkens Roeland

Ended
Caroline Verlinden

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates09/07/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring30/05/2016
    BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring20/01/2016
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates06/11/2014
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other23/12/2010
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202553 k €↑
  2. 2024
    Annual accounts 202422,2 k €↓
  3. 2023
    Annual accounts 202359 k €↑
  4. 2022
    Annual accounts 202237,1 k €↓
  5. 2021
    Annual accounts 202184,1 k €↑
  6. 2015
    Annual accounts 201522,1 k €↑
  7. 2015
    Name changeApharmat
  8. 2014
    Annual accounts 2014-17,4 k €↓
  9. 2013
    Annual accounts 20135,8 k €↓
  10. 2012
    Annual accounts 201226,4 k €↑
  11. 2011
    Annual accounts 201114,1 k €
  12. 2011
    Name changeVERMOO
  13. 26/11/2010
    IncorporationPrivate limited company